Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 9.
C
Ciurtin, C;
Nicolescu, A;
Stefan, L-I;
Kovacs, E;
Smith, ICP;
Deleanu, C;
(2007)
Metabolic profiling of urine by H-1-NMR spectroscopy - A critical assessment of interpreting metabolite concentrations for normal and diabetes groups.
Revista de Chimie
, 58
(1)
pp. 51-55.
|
 |
D
|
Dember, L.M.;
Hawkins, P.N.;
Hazenberg, B.P.C.;
Gorevic, P.D.;
Merlini, G.;
Butrimiene, I.;
Livneh, A.;
... Skinner, M.; + view all
(2007)
Eprodisate for the treatment of renal disease in AA amyloidosis.
New England Journal of Medicine
, 356
(23)
pp. 2349-2360.
10.1056/NEJMoa065644.
|
 |
E
|
Ehrenstein, MR;
Mauri, C;
(2007)
If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicine.
The Journal of Experimental Medicine
, 204
(10)
2249 - 2252.
10.1084/jem.20071737.
|
|
F
|
Fonseca, C;
Lindahl, GE;
Ponticos, M;
Sestini, P;
Renzoni, EA;
Holmes, AM;
Spagnolo, P;
... Abraham, DJ; + view all
(2007)
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
NEW ENGL J MED
, 357
(12)
1210 - 1220.
|
I
|
Ioannou, Y.;
(2007)
Investigating the molecular targets of antiphospholipid antibodies.
Doctoral thesis , University of London.
|
|
J
|
Jury, EC;
Flores-Borja, F;
Kabouridis, PS;
(2007)
Lipid rafts in T cell signalling and disease.
[Review].
Seminars in Cell & Developmental Biology
, 18
(5)
608 - 615.
10.1016/j.semcdb.2007.08.002.
|
|
L
|
Lachmann, HJ;
Goodman, HJB;
Gilbertson, JA;
Gallimore, JR;
Sabin, CA;
Gillmore, JD;
Hawkins, PN;
(2007)
Natural history and outcome in systemic AA amyloidosis.
NEW ENGL J MED
, 356
(23)
2361 - 2371.
|
|
|
Lambrianides, A.;
(2007)
An investigation of the molecular basis of interactions between human monoclonal antibodies and antigens that are clinically relevant in systemic lupus erythematosus and the Antiphospholipid Syndrome.
Doctoral thesis , University of London.
|
|
N
|
Nadkarni, S;
Mauri, C;
Ehrenstein, MR;
(2007)
Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta.
J EXP MED
, 204
(1)
33 - 39.
10.1084/jem.20061531.
|
|
